Exact Mass: 479.2049738
Exact Mass Matches: 479.2049738
Found 238 metabolites which its exact mass value is equals to given mass value 479.2049738
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Nicardipine
C26H29N3O6 (479.20562540000003)
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3803 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3810 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7839; ORIGINAL_PRECURSOR_SCAN_NO 7837 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7818; ORIGINAL_PRECURSOR_SCAN_NO 7816 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7789; ORIGINAL_PRECURSOR_SCAN_NO 7787 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3822; ORIGINAL_PRECURSOR_SCAN_NO 3819 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3811 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3884; ORIGINAL_PRECURSOR_SCAN_NO 3883 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7827; ORIGINAL_PRECURSOR_SCAN_NO 7825 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7806; ORIGINAL_PRECURSOR_SCAN_NO 7805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7845; ORIGINAL_PRECURSOR_SCAN_NO 7843 C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
C26H29N3O6 (479.20562540000003)
nicardipine
C26H29N3O6 (479.20562540000003)
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Cys Met Arg
Ala Cys Arg Met
Ala Asp Phe Gln
Ala Asp Gln Phe
Ala Glu Phe Asn
Ala Glu Asn Phe
Ala Phe Asp Gln
Ala Phe Glu Asn
Ala Phe Asn Glu
Ala Phe Gln Asp
Ala Met Cys Arg
Ala Met Arg Cys
Ala Asn Glu Phe
Ala Asn Phe Glu
Ala Gln Asp Phe
Ala Gln Phe Asp
Ala Arg Cys Met
Ala Arg Met Cys
Cys Ala Met Arg
Cys Ala Arg Met
Cys Cys Arg Val
Cys Cys Val Arg
Cys Glu Lys Thr
Cys Glu Thr Lys
Cys Lys Glu Thr
Cys Lys Thr Glu
Cys Met Ala Arg
Cys Met Arg Ala
Cys Arg Ala Met
Cys Arg Cys Val
Cys Arg Met Ala
Cys Arg Val Cys
Cys Thr Glu Lys
Cys Thr Lys Glu
Cys Val Cys Arg
Cys Val Arg Cys
Asp Ala Phe Gln
Asp Ala Gln Phe
Asp Phe Ala Gln
Asp Phe Gln Ala
Asp Lys Met Ser
Asp Lys Ser Met
Asp Met Lys Ser
Asp Met Ser Lys
Asp Gln Ala Phe
Asp Gln Phe Ala
Asp Ser Lys Met
Asp Ser Met Lys
Glu Ala Phe Asn
Glu Ala Asn Phe
Glu Cys Lys Thr
Glu Cys Thr Lys
Glu Phe Ala Asn
Glu Phe Gly Gln
Glu Phe Asn Ala
Glu Phe Gln Gly
Glu Gly Phe Gln
Glu Gly Gln Phe
Glu Lys Cys Thr
Glu Lys Thr Cys
Glu Asn Ala Phe
Glu Asn Phe Ala
Glu Gln Phe Gly
Glu Gln Gly Phe
Glu Thr Cys Lys
Glu Thr Lys Cys
Phe Ala Asp Gln
Phe Ala Glu Asn
Phe Ala Asn Glu
Phe Ala Gln Asp
Phe Asp Ala Gln
Phe Asp Gln Ala
Phe Glu Ala Asn
Phe Glu Gly Gln
Phe Glu Asn Ala
Phe Glu Gln Gly
Phe Gly Glu Gln
Phe Gly Gln Glu
Phe Asn Ala Glu
Phe Asn Glu Ala
Phe Gln Ala Asp
Phe Gln Asp Ala
Phe Gln Glu Gly
Phe Gln Gly Glu
Gly Glu Phe Gln
Gly Glu Gln Phe
Gly Phe Glu Gln
Gly Phe Gln Glu
Gly Gln Glu Phe
Gly Gln Phe Glu
Lys Cys Glu Thr
Lys Cys Thr Glu
Lys Asp Met Ser
Lys Asp Ser Met
Lys Glu Cys Thr
Lys Glu Thr Cys
Lys Met Asp Ser
Lys Met Ser Asp
Lys Ser Asp Met
Lys Ser Met Asp
Lys Thr Cys Glu
Lys Thr Glu Cys
Met Ala Cys Arg
Met Ala Arg Cys
Met Cys Ala Arg
Met Cys Arg Ala
Met Asp Lys Ser
Met Asp Ser Lys
Met Lys Asp Ser
Met Lys Ser Asp
Met Gln Thr Thr
Met Arg Ala Cys
Met Arg Cys Ala
Met Ser Asp Lys
Met Ser Lys Asp
Met Thr Gln Thr
Met Thr Thr Gln
Asn Ala Glu Phe
Asn Ala Phe Glu
Asn Glu Ala Phe
Asn Glu Phe Ala
Asn Phe Ala Glu
Asn Phe Glu Ala
Asn Pro Ser Tyr
Asn Pro Tyr Ser
Asn Ser Pro Tyr
Asn Ser Tyr Pro
Asn Tyr Pro Ser
Asn Tyr Ser Pro
Pro Asn Ser Tyr
Pro Asn Tyr Ser
Pro Ser Asn Tyr
Pro Ser Tyr Asn
Pro Tyr Asn Ser
Pro Tyr Ser Asn
Gln Ala Asp Phe
Gln Ala Phe Asp
Gln Asp Ala Phe
Gln Asp Phe Ala
Gln Glu Phe Gly
Gln Glu Gly Phe
Gln Phe Ala Asp
Gln Phe Asp Ala
Gln Phe Glu Gly
Gln Phe Gly Glu
Gln Gly Glu Phe
Gln Gly Phe Glu
Gln Met Thr Thr
Gln Thr Met Thr
Gln Thr Thr Met
Arg Ala Cys Met
Arg Ala Met Cys
Arg Cys Ala Met
Arg Cys Cys Val
Arg Cys Met Ala
Arg Cys Val Cys
Arg Met Ala Cys
Arg Met Cys Ala
Arg Val Cys Cys
Ser Asp Lys Met
Ser Asp Met Lys
Ser Lys Asp Met
Ser Lys Met Asp
Ser Met Asp Lys
Ser Met Lys Asp
Ser Asn Pro Tyr
Ser Asn Tyr Pro
Ser Pro Asn Tyr
Ser Pro Tyr Asn
Ser Ser Thr Trp
Ser Ser Trp Thr
Ser Thr Ser Trp
Ser Thr Trp Ser
Ser Trp Ser Thr
Ser Trp Thr Ser
Ser Tyr Asn Pro
Ser Tyr Pro Asn
Thr Cys Glu Lys
Thr Cys Lys Glu
Thr Glu Cys Lys
Thr Glu Lys Cys
Thr Lys Cys Glu
Thr Lys Glu Cys
Thr Met Gln Thr
Thr Met Thr Gln
Thr Gln Met Thr
Thr Gln Thr Met
Thr Ser Ser Trp
Thr Ser Trp Ser
Thr Thr Met Gln
Thr Thr Gln Met
Thr Trp Ser Ser
Val Cys Cys Arg
Val Cys Arg Cys
Val Arg Cys Cys
Trp Ser Ser Thr
Trp Ser Thr Ser
Trp Thr Ser Ser
Tyr Asn Pro Ser
Tyr Asn Ser Pro
Tyr Pro Asn Ser
Tyr Pro Ser Asn
Tyr Ser Asn Pro
Tyr Ser Pro Asn
(S)-trans-N-3-{3-(2-aminocyclopropyl)phenoxy}-1-benzylcarbamoyl propylbenzamide hydrochloride
C27H30ClN3O3 (479.1975580000001)
PROPIONIC ACID (1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYLPROPYL ESTER
C28H33NO4S (479.2130178000001)
(1S,2R)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate
C28H33NO4S (479.2130178000001)
2-Furanyl-[4-[2-(2-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
3-Furanyl-[4-[2-(4-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
3-Furanyl-[4-[2-(3-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
2-[(2R,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
2-[(2S,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
(1R,9S,10S,11S)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C27H27F2N3O3 (479.20203760000004)
2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
(1S,9R,10R,11R)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C27H27F2N3O3 (479.20203760000004)
2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
2-[(2R,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
2-[(2R,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
2-[(2S,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
C23H33N3O6S (479.2089958000001)
3-O-[2-[benzyl(methyl)amino]ethyl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
C26H29N3O6 (479.20562540000003)
1-Ethyl-4-(5-methylfuran-2-carbonyl)-1-(3-morpholin-4-ylpropyl)spiro[indole-3,5-pyrrolidine]-2,2,3-trione
C26H29N3O6 (479.20562540000003)
2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester
C26H29N3O6 (479.20562540000003)
4-{4,8-dimethoxy-2h-pyrido[3,4-b]indol-1-yl}-7-methoxy-1h,2h,3h,4h,12h-5λ⁵-indolo[2,3-a]quinolizin-5-ylium
[C29H27N4O3]+ (479.20830520000004)
1,6',13'-trihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,8'-dione
C26H29N3O6 (479.20562540000003)
(1's,3r,3's,6's,7'r)-1,6',13'-trihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-2,8'-dione
C26H29N3O6 (479.20562540000003)
7',14'-dihydroxy-4',4',7,7-tetramethyl-1h-6'-oxa-10',15'-diazaspiro[chromeno[5,6-b]pyrrole-2,5'-tetracyclo[6.5.2.0¹,¹⁰.0³,⁸]pentadecan]-14'-ene-3,9'-dione
C26H29N3O6 (479.20562540000003)
(1's,2s,3's,7'r,8'r)-7',14'-dihydroxy-4',4',7,7-tetramethyl-1h-6'-oxa-10',15'-diazaspiro[chromeno[5,6-b]pyrrole-2,5'-tetracyclo[6.5.2.0¹,¹⁰.0³,⁸]pentadecan]-14'-ene-3,9'-dione
C26H29N3O6 (479.20562540000003)